1-3 of 3
William Woods
Close
Sort by
Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Pediatric CBF AML Patients Enrolled on Serial CCG/COG Protocols.

Jessica Pollard, Todd Alonzo, Robert Gerbing, Rong Zeng, Betsy Hirsch, Susana Raimondi, Nyla Heerema, William Woods, Beverly Lange, Craig Hurwitz, Robert Arceci, Jerald Radich, Irwin Bernstein, Michael Heinrich, Soheil Meshinchi
Journal: Blood
Blood (2007) 110 (11): 1442.
https://doi.org/10.1182/blood.V110.11.1442.1442
Published: 2007
Journal Articles

Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia.

James Feusner, MD, Haesook Kim, PhD, John Gregory, MD, Todd Alonzo, PhD, William Woods, MD, Howard Weinstein, MD, Martin Tallman, MD
Journal: Blood
Blood (2006) 108 (11): 4494.
https://doi.org/10.1182/blood.V108.11.4494.4494
Published: 2006
Journal Articles

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

John Gregory, MD, Haesook Kim, PhD, Todd Alonzo, MD, Rob Gerbing, PhD, Angela Ogden, MD, William Woods, MD, Howard Weinstein, MD, Lois Shepherd, MD, Charles Schiffer, MD, Frederick Appelbaum, MD, Cheryl Willman, MD, Peter Wiernik, MD, Jacob Rowe, MD, Martin Tallman, MD, James Feusner, MD
Journal: Blood
Blood (2005) 106 (11): 894.
https://doi.org/10.1182/blood.V106.11.894.894
Published: 2005